A citation-based method for searching scientific literature

NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China.
Chao Gao, Shu-Guang Liu, Rui-Dong Zhang, Wei-Jing Li, Xiao-Xi Zhao, Lei Cui, Min-Yuan Wu, Hu-Yong Zheng, Zhi-Gang Li. Br J Haematol 2014
Times Cited: 19






Login to export Results
Don't have an account? Register here

List of co-cited articles
94 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Andrew P Weng, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster. Science 2004
2062
8
42

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.
E Clappier, S Collette, N Grardel, S Girard, L Suarez, G Brunie, S Kaltenbach, K Yakouben, F Mazingue, A Robert,[...]. Leukemia 2010
99
7
36

The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.
C Kox, M Zimmermann, M Stanulla, S Leible, M Schrappe, W-D Ludwig, R Koehler, G Tolle, O R Bandapalli, S Breit,[...]. Leukemia 2010
101
7
36

NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
L Zuurbier, I Homminga, V Calvert, M L te Winkel, J G C A M Buijs-Gladdines, C Kooi, W K Smits, E Sonneveld, A J P Veerman, W A Kamps,[...]. Leukemia 2010
103
7
36

Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.
Stephen Breit, Martin Stanulla, Thomas Flohr, Martin Schrappe, Wolf-Dieter Ludwig, Gabriele Tolle, Margit Happich, Martina U Muckenthaler, Andreas E Kulozik. Blood 2006
192
6
31

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
S Jenkinson, K Koo, M R Mansour, N Goulden, A Vora, C Mitchell, R Wade, S Richards, J Hancock, A V Moorman,[...]. Leukemia 2013
57
6
31

Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
Chao Gao, Xiao-Xi Zhao, Wei-Jing Li, Lei Cui, Wei Zhao, Shu-Guang Liu, Zhi-Xia Yue, Ying Jiao, Min-Yuan Wu, Zhi-Gang Li. Am J Hematol 2012
56
6
31

Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Amélie Trinquand, Aline Tanguy-Schmidt, Raouf Ben Abdelali, Jérôme Lambert, Kheira Beldjord, Etienne Lengliné, Noémie De Gunzburg, Dominique Payet-Bornet, Ludovic Lhermitte, Hossein Mossafa,[...]. J Clin Oncol 2013
160
5
26

High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
Alejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, Arkaitz Carracedo, Leonardo Salmena, Yebin Ahn, Suzanne Dahlberg, Donna Neuberg, Lisa A Moreau, Stuart S Winter,[...]. Blood 2009
334
4
21

The molecular basis of T cell acute lymphoblastic leukemia.
Pieter Van Vlierberghe, Adolfo Ferrando. J Clin Invest 2012
330
4
21

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
Jennifer O'Neil, Jonathan Grim, Peter Strack, Sudhir Rao, Deanne Tibbitts, Christopher Winter, James Hardwick, Markus Welcker, Jules P Meijerink, Rob Pieters,[...]. J Exp Med 2007
515
4
21

PHF6 mutations in T-cell acute lymphoblastic leukemia.
Pieter Van Vlierberghe, Teresa Palomero, Hossein Khiabanian, Joni Van der Meulen, Mireia Castillo, Nadine Van Roy, Barbara De Moerloose, Jan Philippé, Sara González-García, María L Toribio,[...]. Nat Genet 2010
213
4
21

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Adolfo A Ferrando, Donna S Neuberg, Jane Staunton, Mignon L Loh, Christine Huard, Susana C Raimondi, Fred G Behm, Ching Hon Pui, James R Downing, D Gary Gilliland,[...]. Cancer Cell 2002
798
4
21

NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Vahid Asnafi, Agnès Buzyn, Sandrine Le Noir, Frédéric Baleydier, Arnauld Simon, Kheira Beldjord, Oumedaly Reman, Francis Witz, Thierry Fagot, Emmanuelle Tavernier,[...]. Blood 2009
152
4
21

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
Stephen P Hunger, Xiaomin Lu, Meenakshi Devidas, Bruce M Camitta, Paul S Gaynon, Naomi J Winick, Gregory H Reaman, William L Carroll. J Clin Oncol 2012
720
4
21

Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
S Jenkinson, A A Kirkwood, N Goulden, A Vora, D C Linch, R E Gale. Leukemia 2016
53
4
21

The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy.
Valeria Tosello, Adolfo A Ferrando. Ther Adv Hematol 2013
58
4
21

NOTCH1 and FBXW7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia.
Valliyammai Natarajan, Obul R Bandapalli, Thangarajan Rajkumar, Tenali Gnana Sagar, Nirmala Karunakaran. J Pediatr Hematol Oncol 2015
18
4
22

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.
Martin Schrappe, Maria Grazia Valsecchi, Claus R Bartram, André Schrauder, Renate Panzer-Grümayer, Anja Möricke, Rosanna Parasole, Martin Zimmermann, Michael Dworzak, Barbara Buldini,[...]. Blood 2011
261
3
15

Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.
Gannie Tzoneva, Arianne Perez-Garcia, Zachary Carpenter, Hossein Khiabanian, Valeria Tosello, Maddalena Allegretta, Elisabeth Paietta, Janis Racevskis, Jacob M Rowe, Martin S Tallman,[...]. Nat Med 2013
240
3
15

Treating childhood acute lymphoblastic leukemia without cranial irradiation.
Ching-Hon Pui, Dario Campana, Deqing Pei, W Paul Bowman, John T Sandlund, Sue C Kaste, Raul C Ribeiro, Jeffrey E Rubnitz, Susana C Raimondi, Mihaela Onciu,[...]. N Engl J Med 2009
811
3
15

Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
M van Grotel, J P P Meijerink, E R van Wering, A W Langerak, H B Beverloo, J G C A M Buijs-Gladdines, N B Burger, M Passier, E M van Lieshout, W A Kamps,[...]. Leukemia 2008
92
3
15

Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's Oncology Group.
Caroline Hastings, Paul S Gaynon, James B Nachman, Harland N Sather, Xiaomin Lu, Meenakshi Devidas, Nita L Seibel. Br J Haematol 2015
15
3
20

Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia.
Hee Jae Huh, Soo Hyun Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo, Jun Ho Jang, Kihyun Kim, Seok Jin Kim, Won Seog Kim, Chul Won Jung,[...]. Ann Hematol 2013
19
3
15

NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
Obul R Bandapalli, Martin Zimmermann, Corinne Kox, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Rolf Koehler, Martina U Muckenthaler, Andreas E Kulozik. Haematologica 2013
60
3
15

The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.
Benjamin J Thompson, Silvia Buonamici, Maria Luisa Sulis, Teresa Palomero, Tomas Vilimas, Giuseppe Basso, Adolfo Ferrando, Iannis Aifantis. J Exp Med 2007
356
3
15

Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.
Julie Irving, Elizabeth Matheson, Lynne Minto, Helen Blair, Marian Case, Christina Halsey, Isabella Swidenbank, Frida Ponthan, Renate Kirschner-Schwabe, Stefanie Groeneveld-Krentz,[...]. Blood 2014
166
3
15

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.
Teresa Palomero, Maria Luisa Sulis, Maria Cortina, Pedro J Real, Kelly Barnes, Maria Ciofani, Esther Caparros, Jean Buteau, Kristy Brown, Sherrie L Perkins,[...]. Nat Med 2007
679
3
15

NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
Yong-Mei Zhu, Wei-Li Zhao, Jian-Fei Fu, Jing-Yi Shi, Qin Pan, Jiong Hu, Xiao-Dong Gao, Bing Chen, Jun-Min Li, Shu-Min Xiong,[...]. Clin Cancer Res 2006
114
3
15

FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
Myoung-Ja Park, Tomohiko Taki, Megumi Oda, Tomoyuki Watanabe, Keiko Yumura-Yagi, Ryoji Kobayashi, Nobuhiro Suzuki, Junichi Hara, Keizo Horibe, Yasuhide Hayashi. Br J Haematol 2009
89
3
15

WT1 mutations in T-ALL.
Valeria Tosello, Marc R Mansour, Kelly Barnes, Maddalena Paganin, Maria Luisa Sulis, Sarah Jenkinson, Christopher G Allen, Rosemary E Gale, David C Linch, Teresa Palomero,[...]. Blood 2009
88
3
15

Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
Marc R Mansour, Maria L Sulis, Veronique Duke, Letizia Foroni, Sarah Jenkinson, Kenneth Koo, Christopher G Allen, Rosemary E Gale, Georgina Buck, Sue Richards,[...]. J Clin Oncol 2009
79
3
15

Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
Lan Yuan, Ling Lu, Yongchen Yang, Hengjuan Sun, Xi Chen, Yi Huang, Xingjuan Wang, Lin Zou, Liming Bao. Ann Hematol 2015
19
3
15

PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
Rui D Mendes, Leonor M Sarmento, Kirsten Canté-Barrett, Linda Zuurbier, Jessica G C A M Buijs-Gladdines, Vanda Póvoa, Willem K Smits, Miguel Abecasis, J Andres Yunes, Edwin Sonneveld,[...]. Blood 2014
58
3
15

The indicative effect of Notch1 expression for the prognosis of T-cell acute lymphocytic leukemia: a systematic review.
Jiexian Ma, Min Wu. Mol Biol Rep 2012
10
3
30

Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.
Maddalena Paganin, Adolfo Ferrando. Blood Rev 2011
105
3
15

Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia.
Marcela Braga Mansur, Rocio Hassan, Thayana C Barbosa, Alessandra Splendore, Patricia Y Jotta, José Andrés Yunes, Joseph L Wiemels, Maria S Pombo-de-Oliveira. BMC Cancer 2012
32
3
15

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.
L W Ellisen, J Bird, D C West, A L Soreng, T C Reynolds, S D Smith, J Sklar. Cell 1991
1430
3
15

Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.
Linda Fogelstrand, Anna Staffas, Carina Wasslavik, Helene Sjögren, Stefan Söderhäll, Britt-Marie Frost, Erik Forestier, Sofie Degerman, Mikael Behrendtz, Jesper Heldrup,[...]. Pediatr Blood Cancer 2014
24
3
15

KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.
K Malinowska-Ozdowy, C Frech, A Schönegger, C Eckert, G Cazzaniga, M Stanulla, U zur Stadt, A Mecklenbräuker, M Schuster, D Kneidinger,[...]. Leukemia 2015
75
3
15

High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies.
Goda Vaitkevičienė, Erik Forestier, Marit Hellebostad, Mats Heyman, Olafur G Jonsson, Päivi M Lähteenmäki, Susanne Rosthoej, Stefan Söderhäll, Kjeld Schmiegelow. Eur J Haematol 2011
31
2
10

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
C Graux, M Stevens-Kroef, M Lafage, N Dastugue, C J Harrison, F Mugneret, K Bahloula, S Struski, M J Grégoire, N Nadal,[...]. Leukemia 2009
49
2
10

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
Elaine Coustan-Smith, Charles G Mullighan, Mihaela Onciu, Frederick G Behm, Susana C Raimondi, Deqing Pei, Cheng Cheng, Xiaoping Su, Jeffrey E Rubnitz, Giuseppe Basso,[...]. Lancet Oncol 2009
583
2
10

Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia.
Alejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, Jianhua Zhang, Ruta Grebliunaite, Takaomi Sanda, Alexei Protopopov, Valeria Tosello, Jeffery Kutok, Richard S Larson,[...]. J Clin Oncol 2010
69
2
10

The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.
Martine van Grotel, Jules P P Meijerink, H Berna Beverloo, Anton W Langerak, Jessica G C A M Buys-Gladdines, Pauline Schneider, Tim S Poulsen, Monique L den Boer, Martin Horstmann, Willem A Kamps,[...]. Haematologica 2006
72
2
10

Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
Katharine Patrick, Rachel Wade, Nick Goulden, Chris Mitchell, Anthony V Moorman, Clare Rowntree, Sarah Jenkinson, Rachael Hough, Ajay Vora. Br J Haematol 2014
134
2
10

Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition.
Tomasz Szczepanski, Vincent H J van der Velden, Esmé Waanders, Roland P Kuiper, Pieter Van Vlierberghe, Bernd Gruhn, Cornelia Eckert, Renate Panzer-Grümayer, Giuseppe Basso, Hélène Cavé,[...]. J Clin Oncol 2011
50
2
10

Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.
Qian Wang, Huiying Qiu, Hui Jiang, Lili Wu, Shasha Dong, Jinlan Pan, Wenjuan Wang, Nana Ping, Jing Xia, Aining Sun,[...]. Haematologica 2011
56
2
10

RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.
J P Perentesis, S Bhatia, E Boyle, Y Shao, X Ou Shu, M Steinbuch, H N Sather, P Gaynon, W Kiffmeyer, J Envall-Fox,[...]. Leukemia 2004
78
2
10

Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.
Priscila P Zenatti, Daniel Ribeiro, Wenqing Li, Linda Zuurbier, Milene C Silva, Maddalena Paganin, Julia Tritapoe, Julie A Hixon, André B Silveira, Bruno A Cardoso,[...]. Nat Genet 2011
276
2
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.

Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy